{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:29:35Z","timestamp":1789014575446,"version":"build-2803163510"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cancer cells depend on actin cytoskeleton rearrangement to carry out hallmark malignant functions including activation, proliferation, migration and invasiveness. Wiskott\u2013Aldrich Syndrome protein (WASp) is an actin nucleation-promoting factor and is a key regulator of actin polymerization in hematopoietic cells. The involvement of WASp in malignancies is incompletely understood. Since WASp is exclusively expressed in hematopoietic cells, we performed\n                    <jats:italic>in\u00a0silico<\/jats:italic>\n                    screening to identify small molecule compounds (SMCs) that bind WASp and promote its degradation. We describe here one such identified molecule; this WASp-targeting SMC inhibits key WASp-dependent actin processes in several types of hematopoietic malignancies in\u00a0vitro and in\u00a0vivo without affecting na\u00efve healthy cells. This small molecule demonstrates limited toxicity and immunogenic effects, and thus, might serve as an effective strategy to treat specific hematopoietic malignancies in a safe and precisely targeted manner.\n                  <\/jats:p>","DOI":"10.1038\/s41467-021-25842-7","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T06:03:10Z","timestamp":1632290590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Targeting the actin nucleation promoting factor WASp provides a therapeutic approach for hematopoietic malignancies"],"prefix":"10.1038","volume":"12","author":[{"given":"Guy","family":"Biber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviad","family":"Ben-Shmuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Noy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6310-3328","authenticated-orcid":false,"given":"Abhishek","family":"Puthenveetil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neria","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itay","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Feiglin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanay","family":"Ofran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meirav","family":"Kedmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Avigdor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Fried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0305-7438","authenticated-orcid":false,"given":"Mira","family":"Barda-Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"25842_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"25842_CR2","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1023\/A:1008375931236","volume":"10","author":"NL Harris","year":"1999","unstructured":"Harris, N. L. et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann. Oncol. 10, 1419\u201332 (1999).","journal-title":"Ann. Oncol."},{"key":"25842_CR3","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0009-2797(01)00201-0","volume":"135\u2013136","author":"C Ottensmeier","year":"2001","unstructured":"Ottensmeier, C. The classification of lymphomas and leukemias. Chem. Biol. Interact. 135\u2013136, 653\u201364 (2001).","journal-title":"Chem. Biol. Interact."},{"key":"25842_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3322\/canjclin.55.6.368","volume":"55","author":"JO Armitage","year":"2005","unstructured":"Armitage, J. O. Staging non-Hodgkin lymphoma. CA Cancer J. Clin. 55, 368\u201376 (2005).","journal-title":"CA Cancer J. Clin."},{"key":"25842_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00281-004-0165-3","volume":"26","author":"F Baron","year":"2004","unstructured":"Baron, F. & Storb, R. Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review. Springer Semin. Immunopathol. 26, 71\u201394 (2004).","journal-title":"Springer Semin. Immunopathol."},{"key":"25842_CR6","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/1097-0142(19890201)63:3<604::AID-CNCR2820630334>3.0.CO;2-2","volume":"63","author":"RR Love","year":"1989","unstructured":"Love, R. R., Leventhal, H., Easterling, D. V. & Nerenz, D. R. Side effects and emotional distress during cancer chemotherapy. Cancer 63, 604\u2013612 (1989).","journal-title":"Cancer"},{"key":"25842_CR7","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168, 707\u2013723 (2017).","journal-title":"Cell"},{"key":"25842_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1411087","volume":"372","author":"SM Ansell","year":"2015","unstructured":"Ansell, S. M. et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin\u2019s lymphoma. N. Engl. J. Med. 372, 311\u2013319 (2015).","journal-title":"N. Engl. J. Med."},{"key":"25842_CR9","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1182\/bloodadvances.2017012534","volume":"1","author":"RW Merryman","year":"2017","unstructured":"Merryman, R. W., Armand, P., Wright, K. T. & Rodig, S. J. Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma. Blood Adv. 1, 2643\u20132654 (2017).","journal-title":"Blood Adv."},{"key":"25842_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1182\/blood.V128.22.183.183","volume":"128","author":"S Ansell","year":"2016","unstructured":"Ansell, S. et al. A phase 1 study of nivolumab in combination with ipilimumab for relapsed or refractory hematologic malignancies (CheckMate 039). Blood 128, 183\u2013183 (2016).","journal-title":"Blood"},{"key":"25842_CR11","doi-asserted-by":"publisher","unstructured":"Armand, P. et al. A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed\/refractory lymphoid malignancies. Leukemia https:\/\/doi.org\/10.1038\/s41375-020-0939-1 (2020).","DOI":"10.1038\/s41375-020-0939-1"},{"key":"25842_CR12","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","volume":"371","author":"SL Maude","year":"2014","unstructured":"Maude, S. L. et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N. Engl. J. Med. 371, 1507\u20131517 (2014).","journal-title":"N. Engl. J. Med."},{"key":"25842_CR13","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","volume":"377","author":"SJ Schuster","year":"2017","unstructured":"Schuster, S. J. et al. Chimeric antigen receptor T cells in refractory B-cell lymphomas. N. Engl. J. Med. 377, 2545\u20132554 (2017).","journal-title":"N. Engl. J. Med."},{"key":"25842_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejca.2015.11.016","volume":"54","author":"JM Michot","year":"2016","unstructured":"Michot, J. M. et al. Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur. J. Cancer 54, 139\u2013148 (2016).","journal-title":"Eur. J. Cancer"},{"key":"25842_CR15","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/ndt\/gfw467","volume":"32","author":"H Izzedine","year":"2017","unstructured":"Izzedine, H. et al. Renal effects of immune checkpoint inhibitors. Nephrol. Dial. Transplant. 32, 936\u2013942 (2017).","journal-title":"Nephrol. Dial. Transplant."},{"key":"25842_CR16","doi-asserted-by":"publisher","first-page":"16011","DOI":"10.1038\/mto.2016.11","volume":"3","author":"CL Bonifant","year":"2016","unstructured":"Bonifant, C. L., Jackson, H. J., Brentjens, R. J. & Curran, K. J. Toxicity and management in CAR T-cell therapy. Mol. Ther. Oncol. 3, 16011 (2016).","journal-title":"Mol. Ther. Oncol."},{"key":"25842_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrc.2016.40","volume":"16","author":"MR Lieber","year":"2016","unstructured":"Lieber, M. R. Mechanisms of human lymphoid chromosomal translocations. Nat. Rev. Cancer 16, 387\u2013398 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"25842_CR18","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u201374 (2011).","journal-title":"Cell"},{"key":"25842_CR19","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1349-7006.2005.00062.x","volume":"96","author":"D Yamazaki","year":"2005","unstructured":"Yamazaki, D., Kurisu, S. & Takenawa, T. Regulation of cancer cell motility through actin reorganization. Cancer Sci. 96, 379\u2013386 (2005).","journal-title":"Cancer Sci."},{"key":"25842_CR20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.bbamcr.2006.07.001","volume":"1773","author":"H Yamaguchi","year":"2007","unstructured":"Yamaguchi, H. & Condeelis, J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim. Biophys. Acta 1773, 642\u201352 (2007).","journal-title":"Biochim. Biophys. Acta"},{"key":"25842_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10555-008-9166-3","volume":"28","author":"A Hall","year":"2009","unstructured":"Hall, A. The cytoskeleton and cancer. Cancer Metastasis Rev. 28, 5\u201314 (2009).","journal-title":"Cancer Metastasis Rev."},{"key":"25842_CR22","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1182\/blood.V87.10.4340.bloodjournal87104340","volume":"87","author":"RC Bargou","year":"1996","unstructured":"Bargou, R. C. et al. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin\/Reed-Sternberg cells. Blood 87, 4340\u20137 (1996).","journal-title":"Blood"},{"key":"25842_CR23","doi-asserted-by":"publisher","first-page":"5655","DOI":"10.1038\/onc.2013.565","volume":"33","author":"D Nagel","year":"2014","unstructured":"Nagel, D., Vincendeau, M., Eitelhuber, A. C. & Krappmann, D. Mechanisms and consequences of constitutive NF-\u03baB activation in B-cell lymphoid malignancies. Oncogene 33, 5655\u20135665 (2014).","journal-title":"Oncogene"},{"key":"25842_CR24","doi-asserted-by":"publisher","unstructured":"Grywalska, E. et al. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease. Adv. Clin. Exp. Med. https:\/\/doi.org\/10.17219\/acem\/74437 (2018).","DOI":"10.17219\/acem\/74437"},{"key":"25842_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10585-008-9174-2","volume":"26","author":"MF Olson","year":"2009","unstructured":"Olson, M. F. & Sahai, E. The actin cytoskeleton in cancer cell motility. Clin. Exp. Metastasis 26, 273\u201387 (2009).","journal-title":"Clin. Exp. Metastasis"},{"key":"25842_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrc3003","volume":"11","author":"A N\u00fcrnberg","year":"2011","unstructured":"N\u00fcrnberg, A., Kitzing, T. & Grosse, R. Nucleating actin for invasion. Nat. Rev. Cancer 11, 117\u2013187 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"25842_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/intimm\/dxl135","volume":"19","author":"A Konno","year":"2007","unstructured":"Konno, A., Kirby, M., Anderson, S. A., Schwartzberg, P. L. & Candotti, F. The expression of Wiskott-Aldrich syndrome protein (WASP) is dependent on WASP-interacting protein (WIP). Int. Immunol. 19, 185\u201392 (2007).","journal-title":"Int. Immunol."},{"key":"25842_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/(SICI)1097-0029(19991015)47:2<107::AID-JEMT3>3.0.CO;2-H","volume":"47","author":"AJ Thrasher","year":"1999","unstructured":"Thrasher, A. J. & Burns, S. Wiskott-Aldrich syndrome: a disorder of haematopoietic cytoskeletal regulation. Microsc. Res. Tech. 47, 107\u2013113 (1999).","journal-title":"Microsc. Res. Tech."},{"key":"25842_CR29","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1182\/blood-2003-05-1480","volume":"103","author":"K Imai","year":"2004","unstructured":"Imai, K. et al. Clinical course of patients with WASP gene mutations. Blood 103, 456\u201364 (2004).","journal-title":"Blood"},{"key":"25842_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/imr.12114","volume":"256","author":"DA Moulding","year":"2013","unstructured":"Moulding, D. A., Record, J., Malinova, D. & Thrasher, A. J. Actin cytoskeletal defects in immunodeficiency. Immunol. Rev. 256, 282\u201399 (2013).","journal-title":"Immunol. Rev."},{"key":"25842_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/nyas.12049","volume":"1285","author":"MJ Massaad","year":"2013","unstructured":"Massaad, M. J., Ramesh, N. & Geha, R. S. Wiskott-Aldrich syndrome: a comprehensive review. Ann. N. Y. Acad. Sci. 1285, 26\u201343 (2013).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"25842_CR32","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.exphem.2004.12.006","volume":"33","author":"S Andreansky","year":"2005","unstructured":"Andreansky, S. et al. WASP- mice exhibit defective immune responses to influenza A virus, Streptococcus pneumoniae, and Mycobacterium bovis BCG. Exp. Hematol. 33, 443\u2013451 (2005).","journal-title":"Exp. Hematol."},{"key":"25842_CR33","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.imbio.2009.06.009","volume":"214","author":"G Bouma","year":"2009","unstructured":"Bouma, G., Burns, S. O. & Thrasher, A. J. Wiskott-Aldrich syndrome: immunodeficiency resulting from defective cell migration and impaired immunostimulatory activation. Immunobiology 214, 778\u201390 (2009).","journal-title":"Immunobiology"},{"key":"25842_CR34","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1182\/blood-2007-06-096875","volume":"110","author":"G Bouma","year":"2007","unstructured":"Bouma, G., Burns, S. & Thrasher, A. J. Impaired T-cell priming in vivo resulting from dysfunction of WASp-deficient dendritic cells. Blood 110, 4278\u20134284 (2007).","journal-title":"Blood"},{"key":"25842_CR35","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1182\/blood-2010-09-308197","volume":"119","author":"LS Westerberg","year":"2012","unstructured":"Westerberg, L. S. et al. Wiskott-Aldrich syndrome protein (WASP) and N-WASP are critical for peripheral B-cell development and function. Blood 119, 3966\u201374 (2012).","journal-title":"Blood"},{"key":"25842_CR36","doi-asserted-by":"crossref","unstructured":"Tang, Z., Araysi, L. M. & Fathallah-Shaykh, H. M. c-Src and neural Wiskott-Aldrich syndrome protein (N-WASP) promote low oxygen-induced accelerated brain invasion by gliomas. PLoS ONE 8, e75436, 1\u201310 (2013).","DOI":"10.1371\/journal.pone.0075436"},{"key":"25842_CR37","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/cm.20361","volume":"66","author":"V Desmarais","year":"2009","unstructured":"Desmarais, V. et al. N-WASP and cortactin are involved in invadopodium-dependent chemotaxis to EGF in breast tumor cells. Cell Motil. Cytoskeleton 66, 303\u201316 (2009).","journal-title":"Cell Motil. Cytoskeleton"},{"key":"25842_CR38","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1083\/jcb.200708123","volume":"180","author":"C Sarmiento","year":"2008","unstructured":"Sarmiento, C. et al. WASP family members and formin proteins coordinate regulation of cell protrusions in carcinoma cells. J. Cell Biol. 180, 1245\u20131260 (2008).","journal-title":"J. Cell Biol."},{"key":"25842_CR39","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/sj.onc.1208177","volume":"24","author":"S Kurisu","year":"2005","unstructured":"Kurisu, S., Suetsugu, S., Yamazaki, D., Yamaguchi, H. & Takenawa, T. Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells. Oncogene 24, 1309\u20131319 (2005).","journal-title":"Oncogene"},{"key":"25842_CR40","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1128\/MCB.00161-12","volume":"32","author":"B Reicher","year":"2012","unstructured":"Reicher, B. et al. Ubiquitylation-dependent negative regulation of WASp is essential for actin cytoskeleton dynamics. Mol. Cell. Biol. 32, 3153\u20133163 (2012).","journal-title":"Mol. Cell. Biol."},{"key":"25842_CR41","doi-asserted-by":"crossref","unstructured":"Fried, S. et al. Triple-color FRET analysis reveals conformational changes in the WIP-WASp actin-regulating complex. Sci. Signal. 7, 331, ra60, 1\u201312 (2014).","DOI":"10.1126\/scisignal.2005198"},{"key":"25842_CR42","doi-asserted-by":"crossref","unstructured":"Reicher, B. et al. WASp and WAVE proteins: from structure, through function, to clinical aspects. J. Clin. Cell. Immunol. 01, S12, 1\u20137 (2013).","DOI":"10.4172\/2155-9899.S12-008"},{"key":"25842_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/srep44863","volume":"7","author":"N Joseph","year":"2017","unstructured":"Joseph, N. et al. A conformational change within the WAVE2 complex regulates its degradation following cellular activation. Sci. Rep. 7, 44863 (2017).","journal-title":"Sci. Rep."},{"key":"25842_CR44","doi-asserted-by":"publisher","first-page":"6288","DOI":"10.1182\/blood-2008-12-115253","volume":"113","author":"M Bosticardo","year":"2009","unstructured":"Bosticardo, M., Marangoni, F., Aiuti, A., Villa, A. & Grazia Roncarolo, M. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood 113, 6288\u201395 (2009).","journal-title":"Blood"},{"key":"25842_CR45","doi-asserted-by":"publisher","first-page":"8446","DOI":"10.1074\/jbc.M609902200","volume":"282","author":"FC Peterson","year":"2007","unstructured":"Peterson, F. C. et al. Multiple WASP-interacting protein recognition motifs are required for a functional interaction with N-WASP. J. Biol. Chem. 282, 8446\u201353 (2007).","journal-title":"J. Biol. Chem."},{"key":"25842_CR46","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1093\/bioinformatics\/btr294","volume":"27","author":"T Hou","year":"2011","unstructured":"Hou, T., Li, Y. & Wang, W. Prediction of peptides binding to the PKA RIIalpha subunit using a hierarchical strategy. Bioinformatics 27, 1814\u201321 (2011).","journal-title":"Bioinformatics"},{"key":"25842_CR47","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1021\/ci00024a019","volume":"35","author":"A Smellie","year":"1995","unstructured":"Smellie, A., Kahn, S. D. & Teig, S. L. Analysis of conformational coverage. 2. Applications of conformational models. J. Chem. Inf. Comput. Sci. 35, 295\u2013304 (1995).","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"25842_CR48","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1021\/ci049753l","volume":"45","author":"J Kirchmair","year":"2005","unstructured":"Kirchmair, J., Laggner, C., Wolber, G. & Langer, T. Comparative analysis of protein-bound ligand conformations with respect to catalyst\u2019s conformational space subsampling algorithms. J. Chem. Inf. Model. 45, 422\u2013430 (2005).","journal-title":"J. Chem. Inf. Model."},{"key":"25842_CR49","doi-asserted-by":"crossref","unstructured":"Duhovny, D., Nussinov, R. & Wolfson, H. J. In Efficient Unbound Docking of Rigid Molecules BT\u2014Algorithms in Bioinformatics, (eds. Guig\u00f3, R. & Gusfield, D.) 185\u2013200 (Springer Berlin Heidelberg, 2002).","DOI":"10.1007\/3-540-45784-4_14"},{"key":"25842_CR50","doi-asserted-by":"publisher","first-page":"W363","DOI":"10.1093\/nar\/gki481","volume":"33","author":"D Schneidman-Duhovny","year":"2005","unstructured":"Schneidman-Duhovny, D., Inbar, Y., Nussinov, R. & Wolfson, H. J. PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res. 33, W363\u20137 (2005).","journal-title":"Nucleic Acids Res."},{"key":"25842_CR51","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1021\/jm00012a007","volume":"38","author":"M Hahn","year":"1995","unstructured":"Hahn, M. Receptor surface models. 1. Definition and construction. J. Med. Chem. 38, 2080\u20132090 (1995).","journal-title":"J. Med. Chem."},{"key":"25842_CR52","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1080\/07391102.2018.1557559","volume":"37","author":"AS Samorlu","year":"2019","unstructured":"Samorlu, A. S., Yelek\u00e7i, K. & Ibrahim Uba, A. The design of potent HIV-1 integrase inhibitors by a combined approach of structure-based virtual screening and molecular dynamics simulation. J. Biomol. Struct. Dyn. 37, 4644\u20134650 (2019).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"25842_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).","journal-title":"Sci. Rep."},{"key":"25842_CR54","first-page":"1","volume":"12","author":"L Khavrutskii","year":"2013","unstructured":"Khavrutskii, L. et al. Protein purification-free method of binding affinity determination by microscale thermophoresis. J. Vis. Exp. 12, 1\u20136 (2013).","journal-title":"J. Vis. Exp."},{"key":"25842_CR55","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1073\/pnas.0400628101","volume":"101","author":"A Gautreau","year":"2004","unstructured":"Gautreau, A. et al. Purification and architecture of the ubiquitous Wave complex. Proc. Natl Acad. Sci. USA 101, 4379\u201383 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"25842_CR56","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/ni1143","volume":"6","author":"M Barda-Saad","year":"2005","unstructured":"Barda-Saad, M. et al. Dynamic molecular interactions linking the T cell antigen receptor to the actin cytoskeleton. Nat. Immunol. 6, 80\u20139 (2005).","journal-title":"Nat. Immunol."},{"key":"25842_CR57","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/emboj.2010.133","volume":"29","author":"M Barda-Saad","year":"2010","unstructured":"Barda-Saad, M. et al. Cooperative interactions at the SLP-76 complex are critical for actin polymerization. EMBO J. 29, 2315\u20132328 (2010).","journal-title":"EMBO J."},{"key":"25842_CR58","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1128\/MCB.01358-10","volume":"31","author":"MH Pauker","year":"2011","unstructured":"Pauker, M. H., Reicher, B., Fried, S., Perl, O. & Barda-Saad, M. Functional cooperation between the proteins Nck and ADAP is fundamental for actin reorganization. Mol. Cell. Biol. 31, 2653\u201366 (2011).","journal-title":"Mol. Cell. Biol."},{"key":"25842_CR59","doi-asserted-by":"publisher","first-page":"rs3","DOI":"10.1126\/scisignal.2002423","volume":"5","author":"MH Pauker","year":"2012","unstructured":"Pauker, M. H., Hassan, N., Noy, E., Reicher, B. & Barda-Saad, M. Studying the dynamics of SLP-76, Nck, and Vav1 multimolecular complex formation in live human cells with triple-color FRET. Sci. Signal. 5, rs3 (2012).","journal-title":"Sci. Signal."},{"key":"25842_CR60","doi-asserted-by":"publisher","first-page":"34503","DOI":"10.1074\/jbc.M114.591685","volume":"289","author":"MH Pauker","year":"2014","unstructured":"Pauker, M. H. et al. WASp family verprolin-homologous protein-2 (WAVE2) and Wiskott-Aldrich Syndrome Protein (WASp) engage in distinct downstream signaling interactions at the T cell antigen receptor site. J. Biol. Chem. 289, 34503\u201334519 (2014).","journal-title":"J. Biol. Chem."},{"key":"25842_CR61","doi-asserted-by":"publisher","first-page":"ra54","DOI":"10.1126\/scisignal.aad6182","volume":"9","author":"O Matalon","year":"2016","unstructured":"Matalon, O. et al. Dephosphorylation of the adaptor LAT and phospholipase C\u2013\u03b3 by SHP-1 inhibits natural killer cell cytotoxicity. Sci. Signal. 9, ra54\u2013ra54 (2016).","journal-title":"Sci. Signal."},{"key":"25842_CR62","doi-asserted-by":"publisher","first-page":"ra60","DOI":"10.1126\/scisignal.2005198","volume":"7","author":"S Fried","year":"2014","unstructured":"Fried, S. et al. Triple-color FRET analysis reveals conformational changes in the WIP-WASp actin-regulating complex. Sci. Signal. 7, ra60 (2014).","journal-title":"Sci. Signal."},{"key":"25842_CR63","doi-asserted-by":"publisher","first-page":"e96264","DOI":"10.15252\/embj.201696264","volume":"37","author":"O Matalon","year":"2018","unstructured":"Matalon, O. et al. Actin retrograde flow controls natural killer cell response by regulating the conformation state of SHP-1. EMBO J. 37, e96264 (2018).","journal-title":"EMBO J."},{"key":"25842_CR64","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/ni1563","volume":"9","author":"N Shembade","year":"2008","unstructured":"Shembade, N. et al. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat. Immunol. 9, 254\u2013262 (2008).","journal-title":"Nat. Immunol."},{"key":"25842_CR65","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.4049\/jimmunol.151.8.4383","volume":"151","author":"IJ Molina","year":"1993","unstructured":"Molina, I. J., Sancho, J., Terhorst, C., Rosen, F. S. & Remold-O\u2019Donnell, E. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. J. Immunol. 151, 4383\u201390 (1993).","journal-title":"J. Immunol."},{"key":"25842_CR66","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.immuni.2006.06.014","volume":"25","author":"H Zhang","year":"2006","unstructured":"Zhang, H. et al. Impaired integrin-dependent function in Wiskott-Aldrich syndrome protein-deficient murine and human neutrophils. Immunity 25, 285\u2013295 (2006).","journal-title":"Immunity"},{"key":"25842_CR67","first-page":"1","volume":"7","author":"D Ishihara","year":"2012","unstructured":"Ishihara, D., Dovas, A., Park, H., Isaac, B. M. & Cox, D. The chemotactic defect in Wiskott-Aldrich syndrome macrophages is due to the reduced persistence of directional protrusions. PLoS ONE 7, 1\u20139 (2012).","journal-title":"PLoS ONE"},{"key":"25842_CR68","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1182\/blood.V95.9.2943.009k17_2943_2946","volume":"95","author":"R Lorenzi","year":"2000","unstructured":"Lorenzi, R., Brickell, P. M., Katz, D. R., Kinnon, C. & Thrasher, A. J. Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis. Blood 95, 2943\u20136 (2000).","journal-title":"Blood"},{"key":"25842_CR69","doi-asserted-by":"publisher","first-page":"7370","DOI":"10.4049\/jimmunol.0804256","volume":"182","author":"A Astrakhan","year":"2009","unstructured":"Astrakhan, A., Ochs, H. D. & Rawlings, D. J. Wiskott-Aldrich syndrome protein is required for homeostasis and function of invariant NKT cells. J. Immunol. 182, 7370\u201380 (2009).","journal-title":"J. Immunol."},{"key":"25842_CR70","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1189\/jlb.0804444","volume":"77","author":"SB Snapper","year":"2005","unstructured":"Snapper, S. B. et al. WASP deficiency leads to global defects of directed leukocyte migration in vitro and in vivo. J. Leukoc. Biol. 77, 993\u2013998 (2005).","journal-title":"J. Leukoc. Biol."},{"key":"25842_CR71","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1084\/jem.190.9.1329","volume":"190","author":"J Zhang","year":"1999","unstructured":"Zhang, J. et al. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J. Exp. Med. 190, 1329\u201342 (1999).","journal-title":"J. Exp. Med."},{"key":"25842_CR72","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1182\/blood.V90.8.3089","volume":"90","author":"MD Gallego","year":"1997","unstructured":"Gallego, M. D., Santamar\u00eda, M., Pe\u00f1a, J. & Molina, I. J. Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation. Blood 90, 3089\u201397 (1997).","journal-title":"Blood"},{"key":"25842_CR73","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1182\/blood-2004-03-1003","volume":"105","author":"L Westerberg","year":"2005","unstructured":"Westerberg, L. et al. Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response. Blood 105, 1144\u20131152 (2005).","journal-title":"Blood"},{"key":"25842_CR74","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2567.2012.03620.x","volume":"137","author":"F Lafouresse","year":"2012","unstructured":"Lafouresse, F. et al. Wiskott-Aldrich syndrome protein controls antigen-presenting cell-driven CD4 + T-cell motility by regulating adhesion to intercellular adhesion molecule-1. Immunology 137, 183\u2013196 (2012).","journal-title":"Immunology"},{"key":"25842_CR75","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.4049\/jimmunol.1202792","volume":"190","author":"H Ham","year":"2013","unstructured":"Ham, H. et al. Dedicator of cytokinesis 8 interacts with Talin and Wiskott-Aldrich syndrome protein to regulate NK cell cytotoxicity. J. Immunol. 190, 3661\u20133669 (2013).","journal-title":"J. Immunol."},{"key":"25842_CR76","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1182\/blood-2009-07-235804","volume":"115","author":"H Stabile","year":"2010","unstructured":"Stabile, H. et al. Impaired NK-cell migration in WAS\/XLT patients: role of Cdc42\/WASp pathway in the control of chemokine-induced \u03b22 integrin high-affinity state. Blood 115, 2818\u20132826 (2010).","journal-title":"Blood"},{"key":"25842_CR77","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.celrep.2017.12.088","volume":"22","author":"R Houmadi","year":"2018","unstructured":"Houmadi, R. et al. The Wiskott-Aldrich syndrome protein contributes to the assembly of the LFA-1 nanocluster belt at the lytic synapse. Cell Rep. 22, 979\u2013991 (2018).","journal-title":"Cell Rep."},{"key":"25842_CR78","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1146\/annurev.immunol.021908.132554","volume":"27","author":"CL Abram","year":"2009","unstructured":"Abram, C. L. & Lowell, C. A. The ins and outs of leukocyteintegrin signaling. Annu. Rev. Immunol. 27, 339\u2013362 (2009).","journal-title":"Annu. Rev. Immunol."},{"key":"25842_CR79","first-page":"317","volume":"4","author":"A Kupfer","year":"1990","unstructured":"Kupfer, A., Burn, P. & Singer, S. J. The PMA-induced specific association of LFA-1 and talin in intact cloned T helper cells. J. Mol. Cell. Immunol. 4, 317\u201325 (1990).","journal-title":"J. Mol. Cell. Immunol."},{"key":"25842_CR80","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1083\/jcb.201406121","volume":"208","author":"WA Comrie","year":"2015","unstructured":"Comrie, W. A., Babich, A. & Burkhardt, J. K. F-actin flow drives affinity maturation and spatial organization of LFA-1 at the immunological synapse. J. Cell Biol. 208, 475\u201391 (2015).","journal-title":"J. Cell Biol."},{"key":"25842_CR81","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.4049\/jimmunol.148.4.1080","volume":"148","author":"MK Robinson","year":"1992","unstructured":"Robinson, M. K. et al. Antibody against the Leu-CAM beta-chain (CD18) promotes both LFA-1- and CR3-dependent adhesion events. J. Immunol. 148, 1080\u20135 (1992).","journal-title":"J. Immunol."},{"key":"25842_CR82","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1126\/science.1084174","volume":"301","author":"M Kim","year":"2003","unstructured":"Kim, M., Carman, C. V. & Springer, T. A. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 301, 1720\u20135 (2003).","journal-title":"Science"},{"key":"25842_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/srep15031","volume":"5","author":"N Jain","year":"2015","unstructured":"Jain, N. & Thanabalu, T. Molecular difference between WASP and N-WASP critical for chemotaxis of T-cells towards SDF-1\u03b1. Sci. Rep. 5, 15031 (2015).","journal-title":"Sci. Rep."},{"key":"25842_CR84","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1182\/blood-2011-11-390989","volume":"119","author":"MFM de Rooij","year":"2012","unstructured":"de Rooij, M. F. M. et al. The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia. Blood 119, 2590\u20134 (2012).","journal-title":"Blood"},{"key":"25842_CR85","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1084\/jem.20071543","volume":"205","author":"NA Morin","year":"2008","unstructured":"Morin, N. A. et al. Nonmuscle myosin heavy chain IIA mediates integrin LFA-1 de-adhesion during T lymphocyte migration. J. Exp. Med. 205, 195\u2013205 (2008).","journal-title":"J. Exp. Med."},{"key":"25842_CR86","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1242\/jcs.00606","volume":"116","author":"A Smith","year":"2003","unstructured":"Smith, A. LFA-1-induced T cell migration on ICAM-1 involves regulation of MLCK-mediated attachment and ROCK-dependent detachment. J. Cell Sci. 116, 3123\u20133133 (2003).","journal-title":"J. Cell Sci."},{"key":"25842_CR87","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ymeth.2016.09.016","volume":"115","author":"JY Tinevez","year":"2017","unstructured":"Tinevez, J. Y. et al. TrackMate: An open and extensible platform for single-particle tracking. Methods 115, 80\u201390 (2017).","journal-title":"Methods"},{"key":"25842_CR88","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/j.1349-7006.2010.01654.x","volume":"101","author":"S Kurisu","year":"2010","unstructured":"Kurisu, S. & Takenawa, T. WASP and WAVE family proteins: friends or foes in cancer invasion? Cancer Sci. 101, 2093\u20132104 (2010).","journal-title":"Cancer Sci."},{"key":"25842_CR89","doi-asserted-by":"publisher","unstructured":"Biber, G., Ben-Shmuel, A., Sabag, B. & Barda-Saad, M. Actin regulators in cancer progression and metastases: From structure and function to cytoskeletal dynamics. Int. Rev. Cell Mol. Biol. https:\/\/doi.org\/10.1016\/bs.ircmb.2020.05.006 (2020).","DOI":"10.1016\/bs.ircmb.2020.05.006"},{"key":"25842_CR90","first-page":"418","volume":"2003","author":"SK Lee","year":"2003","unstructured":"Lee, S. K. et al. The PreADME Approach: Web-based program for rapid prediction of physico-chemical, drug absorption and drug-like properties. EuroQSAR 2002 Designing Drugs and Crop Protectants: Processes, Problems and Solutions (Blackwell Publishing) 2003, 418\u2013420 (2003).","journal-title":"EuroQSAR 2002 Designing Drugs and Crop Protectants: Processes, Problems and Solutions (Blackwell Publishing)"},{"key":"25842_CR91","doi-asserted-by":"publisher","unstructured":"Chaudhry, M. S., Velardi, E., Malard, F. & Brink, M. R. M. Van Den. Immune reconstitution after allogeneic hematopoietic stem cell transplantation: time to T up the thymus. J. Immunol. https:\/\/doi.org\/10.4049\/jimmunol.1601100 (2017)","DOI":"10.4049\/jimmunol.1601100"},{"key":"25842_CR92","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/NNR.0b013e31818fcecd","volume":"58","author":"D-H Kang","year":"2009","unstructured":"Kang, D.-H. et al. Significant impairment in immune recovery after cancer treatment. Nurs. Res. 58, 105\u201314 (2009).","journal-title":"Nurs. Res."},{"key":"25842_CR93","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1200\/JCO.1998.16.6.2065","volume":"16","author":"H G\u00f3mez","year":"1998","unstructured":"G\u00f3mez, H. et al. Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin\u2019s lymphoma: results of a multivariate analysis. J. Clin. Oncol. 16, 2065\u20139 (1998).","journal-title":"J. Clin. Oncol."},{"key":"25842_CR94","doi-asserted-by":"publisher","first-page":"225","DOI":"10.14740\/jocmr3750","volume":"11","author":"R Bajwa","year":"2019","unstructured":"Bajwa, R. et al. Adverse effects of immune checkpoint inhibitors (programmed death-1 inhibitors and cytotoxic T-lymphocyte-associated protein-4 inhibitors): results of a retrospective study. J. Clin. Med. Res. 11, 225\u2013236 (2019).","journal-title":"J. Clin. Med. Res."},{"key":"25842_CR95","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian, S. L. et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443\u201354 (2012).","journal-title":"N. Engl. J. Med."},{"key":"25842_CR96","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1053\/j.seminhematol.2009.03.005","volume":"46","author":"JW Hiemenz","year":"2009","unstructured":"Hiemenz, J. W. Management of infections complicating allogeneic hematopoietic stem cell transplantation. Semin. Hematol. 46, 289\u2013312 (2009).","journal-title":"Semin. Hematol."},{"key":"25842_CR97","doi-asserted-by":"publisher","unstructured":"Luan, Q., Zelter, A., MacCoss, M. J., Davis, T. N. & Nolen, B. J. Identification of Wiskott-Aldrich syndrome protein (WASP) binding sites on the branched actin filament nucleator Arp2\/3 complex. Proc. Natl. Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.1716622115 (2018).","DOI":"10.1073\/pnas.1716622115"},{"key":"25842_CR98","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1126\/science.257.5073.1078","volume":"257","author":"ID Kuntz","year":"1992","unstructured":"Kuntz, I. D. Structure-based strategies for drug design and discovery. Science 257, 1078\u201382 (1992).","journal-title":"Science"},{"key":"25842_CR99","first-page":"248","volume":"34","author":"H Kubinyi","year":"1979","unstructured":"Kubinyi, H. Nonlinear dependence of biological activity on hydrophobic character: the bilinear model. Farm. Sci. 34, 248\u2013276 (1979).","journal-title":"Farm. Sci."},{"key":"25842_CR100","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1172\/JCI118712","volume":"97","author":"DM Stewart","year":"1996","unstructured":"Stewart, D. M. et al. Studies of the expression of the Wiskott-Aldrich syndrome protein. J. Clin. Invest. 97, 2627\u201334 (1996).","journal-title":"J. Clin. Invest."},{"key":"25842_CR101","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1074\/jbc.M509416200","volume":"281","author":"E Torres","year":"2006","unstructured":"Torres, E. & Rosen, M. K. Protein-tyrosine kinase and GTPase signals cooperate to phosphorylate and activate Wiskott-Aldrich syndrome protein (WASP)\/neuronal WASP. J. Biol. Chem. 281, 3513\u20133520 (2006).","journal-title":"J. Biol. Chem."},{"key":"25842_CR102","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1189\/jlb.2RU0314-162R","volume":"96","author":"S Fried","year":"2014","unstructured":"Fried, S., Matalon, O., Noy, E. & Barda-Saad, M. WIP: more than a WASp-interacting protein. J. Leukoc. Biol. 96, 713\u2013727 (2014).","journal-title":"J. Leukoc. Biol."},{"key":"25842_CR103","doi-asserted-by":"publisher","first-page":"7629","DOI":"10.3390\/ijms13067629","volume":"13","author":"E Noy","year":"2012","unstructured":"Noy, E., Fried, S., Matalon, O. & Barda-Saad, M. WIP remodeling actin behind the scenes: how WIP reshapes immune and other functions. Int. J. Mol. Sci. 13, 7629\u201347 (2012).","journal-title":"Int. J. Mol. Sci."},{"key":"25842_CR104","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.4049\/jimmunol.162.8.5019","volume":"162","author":"DM Stewart","year":"1999","unstructured":"Stewart, D. M., Tian, L. & Nelson, D. L. Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein. J. Immunol. 162, 5019\u20135024 (1999).","journal-title":"J. Immunol."},{"key":"25842_CR105","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.1038\/onc.2010.323","volume":"29","author":"MA Davies","year":"2010","unstructured":"Davies, M. A. & Samuels, Y. Analysis of the genome to personalize therapy for melanoma. Oncogene 29, 5545\u20135555 (2010).","journal-title":"Oncogene"},{"key":"25842_CR106","first-page":"4682","volume":"49","author":"J Bos","year":"1989","unstructured":"Bos, J. L. ras oncogenes in human cancer: a review. Cancer Res. 49, 4682\u20139 (1989).","journal-title":"Cancer Res."},{"key":"25842_CR107","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","volume":"170","author":"DK Simanshu","year":"2017","unstructured":"Simanshu, D. K., Nissley, D. V. & McCormick, F. RAS proteins and their regulators in human disease. Cell 170, 17\u201333 (2017).","journal-title":"Cell"},{"key":"25842_CR108","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature03841","volume":"436","author":"M Braig","year":"2005","unstructured":"Braig, M. et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436, 660\u20135 (2005).","journal-title":"Nature"},{"key":"25842_CR109","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3390\/cells8070646","volume":"8","author":"C Voena","year":"2019","unstructured":"Voena, C. & Chiarle, R. RHO family GTPases in the biology of lymphoma. Cells 8, 646 (2019).","journal-title":"Cells"},{"key":"25842_CR110","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/onc.2016.366","volume":"36","author":"CA Murga-Zamalloa","year":"2017","unstructured":"Murga-Zamalloa, C. A. et al. NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma. Oncogene 36, 2085\u20132094 (2017).","journal-title":"Oncogene"},{"key":"25842_CR111","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar, D. S. et al. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19, 649\u2013658 (2017).","journal-title":"Neoplasia"},{"key":"25842_CR112","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1432-1033.1977.tb11885.x","volume":"80","author":"FC BERNSTEIN","year":"1977","unstructured":"BERNSTEIN, F. C. et al. The Protein Data Bank. A computer-based archival file for macromolecular structures. Eur. J. Biochem. 80, 319\u2013324 (1977).","journal-title":"Eur. J. Biochem."},{"key":"25842_CR113","doi-asserted-by":"publisher","first-page":"e1000976","DOI":"10.1371\/journal.pcbi.1000976","volume":"6","author":"SL Kinnings","year":"2010","unstructured":"Kinnings, S. L. et al. The Mycobacterium tuberculosis drugome and its polypharmacological implications. PLoS Comput. Biol. 6, e1000976 (2010).","journal-title":"PLoS Comput. Biol."},{"key":"25842_CR114","doi-asserted-by":"crossref","unstructured":"Ho, T. K. Random decision forests. In Proceedings of 3rd International Conference on Document Analysis and Recognition, vol. 1, 278\u2013282 (IEEE Comput. Soc. Press, 1995).","DOI":"10.1109\/ICDAR.1995.598994"},{"key":"25842_CR115","first-page":"18","volume":"2","author":"A Liaw","year":"2002","unstructured":"Liaw, A. & Wiener, M. Classification and Regression by Random Forest. R News, 2, 18\u201322 (2002).","journal-title":"R News"},{"key":"25842_CR116","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"25842_CR117","doi-asserted-by":"publisher","first-page":"e0232565","DOI":"10.1371\/journal.pone.0232565","volume":"15","author":"A Suarez-Arnedo","year":"2020","unstructured":"Suarez-Arnedo, A. et al. An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays. PLoS ONE 15, e0232565 (2020).","journal-title":"PLoS ONE"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25842-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25842-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25842-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T14:04:57Z","timestamp":1725804297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25842-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":117,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["25842"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-25842-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,22]]},"assertion":[{"value":"16 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"\u201cWASp-protecting small molecules, compositions, methods and uses thereof in the treatment of innate and acquired immune-related disorders or conditions\u201d PCT\/IB2014\/061907, patent author: M.B.S. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5581"}}